Application 218054
- Type
- ANDA
- Sponsor
- INDIES PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | REGADENOSON | REGADENOSON | SOLUTION;INTRAVENOUS | 0.4MG/5ML (0.08MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218054-001 | REGADENOSON | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218054-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218054-001 | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218054-001 | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218054-001 | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218054-001 | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218054-001 | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218054-001 | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218054-001 | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218054-001 | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218054-001 | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A218054-001 | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 | d06236e962d9… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218054-001 | REGADENOSON | 0.4MG/5ML (0.08MG/ML) | SOLUTION / INTRAVENOUS | AP | 2024-08-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218054-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218054-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A218054-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218054-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218054-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218054-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218054-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218054-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218054-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A218054-001 | AP | 1 | d06236e962d9… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218054-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Regadenoson | REGADENOSON | Indies Pharma Jamaica Limited | 5095ab40-8503-46db-9b08-6a36f05fb5d9 | 2025-12-26 | Warnings, Adverse reactions | 218054 ANDA218054 |
| Regadenoson | REGADENOSON | Kanchan Healthcare Inc | b183399d-b8dc-4924-90cd-a1c2247742f3 | 2025-08-15 | Warnings, Adverse reactions | 218054 ANDA218054 |
| Regadenoson | REGADENOSON | Marlex Pharmaceuticals, Inc. | 843bfba9-47de-4d76-843a-997bb4564f6e | 2025-02-02 | Warnings, Adverse reactions | 218054 ANDA218054 |